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Summary
We have developed an immunochromatographic test for the diagnosis of peste
des petits ruminants (PPR) under field conditions. The diagnostic assay has been
tested in the laboratory and also under field conditions in Ivory Coast, Pakistan,
Ethiopia and Uganda. The test is carried out on a superficial swab sample (ocular
or nasal) and showed a sensitivity of 84% relative to PCR. The specificity was
95% over all nasal and ocular samples. The test detected as little as 103 TCID50
(50% tissue culture infectious doses) of cell culture-grown virus, and detected
virus isolates representing all four known genetic lineages of peste des petits rumi-
nants virus. Virus could be detected in swabs from animals as early as 4 days
post-infection, at a time when clinical signs were minimal. Feedback from field
trials was uniformly positive, suggesting that this diagnostic tool may be useful
for current efforts to control the spread of PPR.
Introduction
Peste des petits ruminants (PPR) is a viral disease of sheep
and goats which has shown rapid spread throughout large
parts of the developing world in the last 20 years (Banyard
et al., 2010; Kwiatek et al., 2011). It is now found in most
countries in Africa as far south as Tanzania, throughout the
Near and Middle East and in large parts of Asia, including
a recent outbreak in China that has reached from the wes-
tern border with Tajikistan to the eastern borders with Rus-
sia and North Korea in <4 months (OIE, 2014). The
disease is characterized by fever, congestion in, and dis-
charge from, the eyes and nose, respiratory problems, ero-
sive sores in the mouth, lesions around the outside of the
mouth, possibly swelling of the lips and diarrhoea,
although not all signs are seen in all infected animals. Mor-
tality can be up to 80%, although it is more commonly
around 30%, and morbidity is very high (>90%) (reviewed
in Baron et al., 2011; Albina et al., 2013; Couacy-Hymann
et al., 2007). The economic impact of the disease, and its
propensity for rapid spread through the movement of
infected animals, has led to the disease being notifiable to
the World Organisation for Animal Health (OIE).
One of the problems limiting efforts to control the
spread of the disease is that of quickly and correctly identi-
fying outbreaks. The disease is often unfamiliar to livestock
keepers in communities dependent on sheep or goats. The
set of clinical signs elicited by PPR virus (PPRV) can vary
depending on the breed of host and the strain of virus, and
it can be hard to distinguish PPR from other diseases of
small ruminants such as ‘orf’, contagious caprine pleuro-
pneumonia (CCPP) or bluetongue. This means that
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veterinarians, to take disease-appropriate action, must
either be able to correctly identify the disease from the
signs, based on experience, or wait for samples to be sent to
a regional or national laboratory and for the results of labo-
ratory tests to be sent back, which may take several days.
This kind of delay will inevitably lead to increased disper-
sion of the disease, as firm control measures will not be
applied until a definitive diagnosis is available. In addition,
the separation in time and distance of field sampling and
final laboratory test result decreases the incentive for field
workers to submit samples, leading to inefficient monitor-
ing and delayed diagnosis.
This situation would be alleviated to some extent if
diagnosis could be made in the field/at the pen side. For
PPRV, the currently available diagnostic tests (agarose gel
immunodiffusion (AGID), enzyme-linked immunosorbent
assay (ELISA), reverse transcription–polymerase chain
reaction (RT-PCR), either gel-based or real-time, or loop-
mediated isothermal amplification (LAMP) (OIE, 2012))
vary in their technical demands, but all require a labora-
tory, particularly for molecular techniques such as RT-
PCR or LAMP. We have developed a pen side test for
PPRV based on immunochromatographic lateral flow
technology (reviewed in Posthuma-Trumpie et al., 2009).
The device has been tested in the laboratory, under con-
trolled conditions with experimentally infected animals
and in the field during actual or suspected outbreaks in
several countries where PPR is endemic. The test has pro-
ven itself reliable and sensitive and will provide an impor-
tant tool in the campaign to control and eventually roll
back the spread of this disease.
Materials and Methods
Isolates of PPRV used in laboratory tests and tests with
experimental animals were from the archive of viruses avail-
able at The Pirbright Institute and were grown and titred in
Vero cells expressing the canine form of the morbillivirus
receptor, Signalling Lymphocyte Activation Molecule
(SLAM) (CD150), as previously described (Chinnakannan
et al., 2013). Confirmatory PCR assays were carried out
using published procedures (Forsyth and Barrett, 1995;
Couacy-Hymann et al., 2002; Batten et al., 2011), although
different tests were used in different laboratories.
All animal studies were carried out under project licences
issued by the UK Home Office, after approval by The Pir-
bright Institute Animal Welfare and Ethical Review Body
(AWERB). All staff carrying out procedures on animals had
appropriate personal licences issued by the UK Home
Office.
The lateral flow device (LFD)-based test for PPRV was
manufactured by Foresite Diagnostics Ltd, Sand Hutton,
York, UK, using monoclonal antibody C77 recognizing the
H protein of PPRV (Anderson et al., 1990; Anderson and
McKay, 1994). The stocks of C77 were prepared using
hybridoma cells grown in a miniPerm bioreactor and puri-
fied on a Protein G HiTrap column (GE Healthcare Life
Sciences, Bucks, UK).
Swab samples from animals were taken on artificial fibre
(‘Floq’) or cotton swabs; material from the swabs was
eluted in 500–600 ul of LFD buffer ‘TBCE’ (Foresite) and
80–100 ul of the eluate applied to the test strip. Prepara-
tions of cell culture-grown viruses were diluted as required
into LFD buffer such that 80 ul contained the required
dose of virus, which was applied to the test. Tissue extracts
were prepared from samples stored at 80°C; approx.
0.5 g tissue was ground in a mortar with 30 drops of LFD
buffer, the material transferred to a test tube along with a
further 20 drops LFD buffer which was used to wash the
mortar, and spun at 2500 g for 5 mins. Six drops of the
supernatant were transferred to a LFD and developed as
normal.
Developed tests were scanned or photographed after 15–
30 mins. Scans/photographs were rotated and cropped as
required in Adobe Photoshop.
Results and Discussion
Prototype development and laboratory testing
The LFD-based PPRV test is based on the specificity and
affinity of monoclonal antibody C77. This antibody recog-
nizes the PPRV H protein, but not that of the related rumi-
nant morbillivirus rinderpest (Anderson et al., 1990;
Anderson and McKay, 1994; Das et al., 2000); it is the basis
of a widely used competition ELISA for PPRV antibodies
(Anderson et al., 1990; Anderson and McKay, 1994) and
has previously been used in a prototype penside test for
PPRV (Br€uning-Richardson et al., 2011). This monoclonal
antibody is used both as the trapping reagent on the chro-
matographic test strip and to decorate the detection beads
(Fig. 1a), which are either latex (blue) or colloidal gold
(red) (Fig. 1b). The specificity of the antibody thereby
ensures the specificity of the test.
In collaboration with the manufacturers, we screened a
large number of prototype tests to see which combination
of filter strip, buffer and beads would give a sufficiently sen-
sitive test. In determining the criteria by which we would
assess prototype tests, we estimated the amount of virus
that might be found in swabs from PPRV-infected animals.
Previous studies in the reference laboratory at The Pir-
bright Institute had shown that our real-time PCR assay
(Batten et al., 2011) gave a similar result with extracts from
an ocular or nasal swab as seen with 103 TCID50 of cell cul-
ture-grown PPRV. While such a swab might contain more
viral antigen than found in this amount of cell culture-
grown PPRV, we reasoned it was unlikely to contain less, as
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swab material would contain also dead cells and other host
animal material which could contain non-infectious or no
longer infectious viral antigen. We therefore set detection
of 103 TCID50 of PPRV as our primary criterion for accept-
ability of a test. Two prototypes from the third batch of
tests (3.3 and 3.5) showed clear positive results with this
amount of PPRV (Fig. 1b). These prototypes recognized
PPRV isolates representing all four known lineages of the
virus (Fig. 1c), as expected from the known ability of C77
to recognize all lineages of PPRV. The variation observed in
the intensity of the ‘Test’ band obtained with different iso-
lates was found to depend on the dilution of virus stock
required to give 103 TCID50 in 80 ul; the greater the dilu-
tion, the weaker the band seen in the test. This observation
is in accord with our experience that laboratory-grown
stocks of virus contain variable amounts of non-infectious
viral antigen and RNA as well as protein and RNA derived
from the cultured cells. Normal preparations of tissue cul-
ture-grown virus contain significant amounts of micropar-
ticulate cell debris from the freeze–thaw cycling of the cells,
which is used to release the virus; it is probable that this
material contains viral antigen which can contribute to the
positive result in the test. It cannot be excluded that some
strain-specific variation in sensitivity of the test exists,
which may occur within or between lineages. This may be
the result of antigenic variation or of differences between
strains in the excretion of virus antigen into eye or nose
discharge. The latter possibility is a problem that affects all
kinds of tests detecting virus antigen. While such variations
in sensitivity with strain may occur, it does not appear to
be sufficient to prevent the test detecting virus from a range
of different countries and of different genetic lineages.
The LFD-based test was applied to swabs taken from a
number of UK sheep and goats as negative controls, as
(a)
(b) (c)
Fig. 1. Screening and laboratory testing of lateral flow device (LFD)-based assay. (a) Basic operation of the immunochromatographic assay. Sample is
added to the test port where it mixes with beads in the reagent pad (i). Any virus antigen in the sample binds to beads there. Beads are carried by
chromatographic flow along the test strip to the test line, where they encounter further anti-PPRV antibody (ii). Any virus or virus antigen bound to
the beads will be immobilized on the test line, thereby immobilizing some of the beads and creating a positive signal. Remaining beads are carried fur-
ther along the strip until they come to the control line, where they are bound by anti-mouse IgG antibody. (b) Screening of prototypes 3.1–3.5 with
103 and 104 TCID50 of PPRV (strain Sudan/72). (c) Confirmation of the ability of the device to recognize virus from all known lineages. Prototype 3.5
was used to screen 103 TCID50 of cell culture-grown virus of each strain.
© 2014 Blackwell Verlag GmbH • Transboundary and Emerging Diseases. 3
J. Baron et al. Field Test for PPRV
there is no known PPR in the UK, nor has there ever been.
All these tests gave negative results, as expected (Fig. 2a).
(Note that different batches of the test came mounted in
slightly different plastic cases; this did not affect the internal
contents of the tests nor their performance). In addition,
no positive result was seen when the test was used on swabs
from UK sheep that had been experimentally infected with
bluetongue virus (BTV) (Fig. 2b); BTV infection can give
rise to similar signs as PPRV (fever, nasal discharge) and
could easily give rise to suspicion of PPRV in the field. We
took the swabs at the stage of strong clinical signs, but no
positive result was observed in the PPRV test.
Lateral flow device-based tests were also used on samples
from animals experimentally infected with PPRV (Baron
et al., 2014). At 4 days post-infection (dpi), most animals
were showing a rise in rectal temperatures, but no other
clinical signs, so they would be unlikely to have been spot-
ted as infected by a livestock keeper in field conditions. At
7 dpi, the animals were showing nasal and ocular conges-
tion, and some animals had a slight ocular or nasal dis-
charge. Positive results from the LFD were seen in some
animals at 4 dpi, and in all animals at 7 dpi (Fig. 2c).
These observations showed that the test can detect PPRV
even at early stages of infection. The remaining swab eluate
from these samples was assayed for PPRV genome RNA by
real-time PCR; the swab eluates were also found to be posi-
tive for virus by PCR, although perfect correlation was not
observed between the swab results and the PCR test, espe-
cially at 4 dpi. This may have been due to the LFD buffer
not being optimized for RNA preservation, or variation in
the ratio of viral membrane antigen to viral genome in dif-
ferent animals.
Field testing of the PPRV penside test
Peste des petits ruminants virus penside tests were distrib-
uted to a number of centres in countries where PPRV is, or
has recently been, prevalent (Pakistan, Ethiopia, Ivory
Coast, Uganda). Tests were used to assay fresh or archived
swabs, or in one case to assay extracts of frozen tissue from
experimental animals. Swabs were taken primarily from eye
or nose, although some samples were taken from mouth or
faeces. In all cases, the result from the test was confirmed
using gel-based or real-time PCR, depending on the labora-
tory. These results, together with results from animals
tested in the UK, are collected in Table 1. As can be seen,
there was very good correlation between the test result and
the result from the corresponding PCR of the same sample.
In a small number of cases, usually associated with a weak
PCR result, the pen side test failed to detect PPRV, but this
was expected, as the penside test is essentially a pocket form
of immunocapture ELISA, and was not going to be as sensi-
tive as PCR, which can detect a few 10 s of copies of the
virus genome. The calculated sensitivity, relative to PCR,
and taken over the ocular and nasal swabs, was 84%, with a
calculated specificity of 95%. We did observe a small frac-
tion of nasal swabs, although no eye swabs, which were
unambiguously positive for PPRV in the penside test, but
(a) (b)
(c)
Fig. 2. Testing of lateral flow device (LFD) based on animal samples (a) Examples of eye swabs or nasal swabs from uninfected UK sheep tested on
the LFD-based assays. (b) Examples of eye swabs or nasal swabs taken from animals with severe bluetongue and tested on the LFD-based assays. (c)
Examples of nasal swabs taken from UK goats infected with PPRV. Swabs were taken 4 or 7 dpi as indicated and tested on the LFD-based assays; the
remaining eluate from each swab was tested for PPRV genome by real-time PCR, and the result recorded as the Ct determined in the PCR assay.
© 2014 Blackwell Verlag GmbH • Transboundary and Emerging Diseases.4
Field Test for PPRV J. Baron et al.
negative in PCR. It is unknown whether this is due to genu-
ine false positives from nasal samples, or some component
of nasal mucous which is inhibitory in RT-PCR in the same
way that heparin is known to be (Beutler et al., 1990; Holo-
dniy et al., 1991).
For a number of animals, replicate samples were taken
from eye and nose, and in some cases from mouth or fae-
ces. These data are summarized in Table 2. No significant
difference was seen in the sensitivity of nasal and oral
swabs, although both were superior to oral or faecal swabs.
In general, these observations suggest eye swabs are the
most useful sample type to be used in the field, especially if
the sample is to be transferred to a laboratory for further
testing (e.g. PCR for sequencing and lineage determina-
tion).
No problem was reported in carrying out the test away
from the laboratory. No extra equipment is required apart
from the swabs, a tube containing LFD buffer and a plastic
transfer pipette for applying the swab extract to the test.
One group subdivided the kit, which contains 25 tests, to
provide packets of 2–5 tests to be used on any one field
visit.
The test was also able to identify PPRV in extracts of fro-
zen tissues (Table 1), although this reduces the test to the
status of laboratory assay, where it offers no advantage over
the traditional icELISA, and is more expensive. Using the
test in this way may, in some cases, be convenient, for
example if it is necessary to use in an emergency in labora-
tories where normal assays for PPRV have not yet been
established.
Table 1. Compilation of results of lateral flow device (LFD) (penside) PPRV test compared with laboratory test results. For each test used, we tabu-
lated the type of sample and the result (+/) of the LFD test and the corresponding PCR test for PPRV. Assuming that the PCR test is a definitive test
for infection with PPRV, the sensitivity of the test for ocular/nasal swabs was 83.54% (95% CI: 73.5–90.9%) while the specificity was 94.59% (95%
CI: 86.7–98.5%)
Sample type Sample origin
Number
of samples
PCR neg;
LFD neg
PCR neg;
LFD pos
PCR pos;
LFD neg
PCR pos;
LFD pos
Nasal swabs UK (known clean)a 12 12 0 – –
UK (known ve)a 10 10 0 – –
UK (known +ve)a 27 0 1 4 22
Ivory Coastb 18 9 0 0 9
Ugandab 8 1 2 0 5
Pakistanc 21 4 1 3 13
Eye swabs UK(known clean)a 8 8 0 – –
UK (known ve)a 5 5 0 – –
Ivory Coastb 16 7 0 1 8
Ethiopiab 10 10 0 0 0
Pakistanc 18 4 0 5 9
Oral swabs Ivory Coastb 10 2 0 4 4
Faecal swabs Pakistanc 10 5 0 3 2
Tissue homogenate Ethiopiab 9 0 0 2 7
aPCR tests for PPRV were carried out in the UK using real-time PCR as described in Batten et al. (2011). Note that, for UK animals that were known to
be free of PPRV, the PCR test was not carried out but can be assumed to be negative.
bPCR tests for PPRV were carried out in Ivory Coast, Ethiopia and Uganda using conventional (gel-based) PCR as described in Couacy-Hymann et al.
(2002).
cPCR tests for PPRV were carried out in Pakistan using real-time PCR as described in Kwiatek et al. (2010).
Table 2. Detailed results from animals sampled at multiple points. Ani-
mals 1–8 were from Pakistan; animals 9–17 were from Ivory Coast. PCR
status (whether the animal was infected with PPRV or not according to
PCR-based tests on nasal and eye swabs) was determined using the
assays given in Table 1
Animal Status (PCR)
LFD
Nasal Eye Oral Faecal
1 +ve +ve +ve ND ve
2 +ve +ve ve ND ve
3 +ve +ve ve ND +ve
4 +ve ve +ve ND ND
5 +ve +ve +ve ND ve
6 +ve ve ve ND ve
7 +ve +ve +ve ND ND
8 +ve +ve +ve ve ND
9 +ve +ve +ve ve ND
10 +ve +ve +ve +ve ND
11 +ve +ve +ve +ve ND
12 +ve +ve +ve ve ND
13 ve ve ve ve ND
14 ve ve ve ve ND
15 +ve +ve +ve ve ND
16 +ve +ve +ve +ve ND
17 +ve +ve +ve +ve ND
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An acknowledged criticism of this sort of test is that the
result can be subjective; while negatives have no line at the
T position, and strong positives are very clear, it is possible
for samples with little virus (e.g. some of the samples at
4 dpi in Fig. 2) to be open to question as to whether they
are positive or not. Objective evaluation of the test results
would require an optical or electrochemical reader or other
device. This would probably raise the sensitivity of the test,
but the need for such a device would greatly raise the cost
of the test as well as make it impractical for field use in
developing countries. The benefits of using the penside test
are primarily the ability to confirm or deny PPRV infection
far more quickly than would be possible using laboratory-
based testing. This means that the implementation of
movement controls and the initiation of vaccination or
stamping out can be put in place with the minimum delay.
Where clinical knowledge and experience of PPR is limited,
for example in countries or areas where the disease has only
recently arrived, or where outbreaks have been too sporadic
to build up local knowledge, a negative result can be impor-
tant in removing concerns of a new PPR outbreak. The test
gives a clear result, which could be easily photographed
using a smart phone, such as are common even in develop-
ing world countries, and the photograph transmitted back
to a central veterinary office or laboratory as confirmation
that a reported disease is or is not PPR. The test does not
require special training and could be used by livestock
keepers, veterinary technicians (paravets) or veterinary offi-
cers, depending on local need. It is expected that this test
will prove a useful addition to the tools available, given the
extensive spread of PPR over the past 10 years, and grow-
ing interest in establishing proper control of this economi-
cally very important disease (Baron et al., 2011; Albina
et al., 2013).
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